Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices 15579 

appropriate; (4) advise on grants, 

cooperative agreements, contracts, or 

other transactions, as applicable; (5) 

provide other advice to the Director, as 

requested, to fulfill duties under 

sections 301 and 311; and (6) appoint 

subcommittees. The ACD, CDC consists 

of up to 15 non-federal members, 

including the Chair, knowledgeable in 

areas pertinent to the CDC mission, such 

as health policy, public health, global 

health, preparedness, preventive 

medicine, the faith-based and 

community-based sector, and allied 

fields. 

Purpose: The establishment and 

formation of the ACD, Communications 

and Public Engagement Workgroup 

(CPEW) is to provide input to the 

Committee on agency-wide activities 

related to how CDC communicates 

directly and more effectively with the 

public, with a focus on reaching local 

communities with messages. Effective 

communication with the public 

includes, but is not limited to: (1) 

building relationships and mechanisms 

to communicate via trusted messengers, 

including but not limited to, clinicians, 

faith and community leaders, and health 

department officials at the national, 

state and local levels; (2) improving risk 

communication practices; (3) delivering 

more action-oriented and focused 

communications to help people protect 

their health (e.g., effective messages and 

storytelling); (4) tailoring our messages 

and communications methods, as 

appropriate, to audiences, particularly 

for historically marginalized 

communities; and (5) increasing 

transparency by stepping up the pace, 

content and reach of our 

communications (e.g., considering 

impact of different communications 

channels, such as blogs, TV interviews, 

emerging platforms). 

The CPEW membership consists of 

approximately 15 members. It is cochaired by two current ACD, CDC 

Special Government Employees. The 

CPEW co-chairs will present their 

findings, observations, and work 

products at one or more ACD, CDC 

meetings for discussion, deliberation, 

and decisions (final recommendations 

to CDC). 

Nomination Criteria: CPEW members 

will serve terms ranging from six 

months to one year and be required to 

attend CPEW meetings approximately 

once per month (virtually or in person), 

and contribute time in between 

meetings for research, consultation, 

discussion, and writing assignments. 

Nominations are being sought for 

individuals who have the expertise and 

qualifications necessary to contribute to 

the accomplishments of the 

committee’s/workgroup’s objectives. 

Nominees will be selected based on 

expertise in the fields of 

communications, including public 

relations, health communication, risk 

communication, communication 

research, and marketing; community 

and partner engagement; public health 

science and practice, including 

implementation; and behavioral 

science/behavior change campaigns. 

Federal employees will not be 

considered for membership. Selection of 

members is based on candidates’ 

qualifications to contribute to the 

accomplishment of the CPEW’s 

objectives. 

HHS policy stipulates that 

membership be balanced in terms of 

points of view represented and the 

workgroup’s function. Appointments 

shall be made without discrimination 

based on age, race, ethnicity, gender, 

sexual orientation, gender identity, HIV 

status, disability, and cultural, religious, 

or socioeconomic status. Nominees 

must be U.S. citizens and cannot be fulltime employees of the U.S. Government. 

Current participation on federal 

workgroups or prior experience serving 

on a federal advisory committee does 

not disqualify a candidate; however, 

HHS policy is to avoid excessive 

individual service on advisory 

committees and multiple committee 

memberships. Interested candidates 

should submit the following items: 

• A one-half to one-page cover letter 

that includes your understanding of, 

and commitment to, the time and work 

necessary; one to two sentences on your 

background and experience; and one to 

two sentences on the skills/perspective 

you would bring to the CPEW. 

• At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. 

(Candidates may submit letter(s) from 

current HHS employees if they wish, 

but at least one letter must be submitted 

by a person not employed by an HHS 

agency (e.g., CDC, NIH, FDA, etc.). 

• Current curriculum vitae which 

highlights the experience and work 

history being sought relevant to the 

criteria set forth above, including 

complete contact information 

(telephone numbers, mailing address, 

email address). 

Nominations may be submitted by the 

candidate him or herself, or by the 

person/organization recommending the 

candidate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–04430 Filed 3–1–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Mine Safety and Health 

Research Advisory Committee 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Mine Safety 

and Health Research Advisory 

Committee (MSHRAC). This is a hybrid 

meeting, accessible both in person and 

virtually. It is open to the public and 

limited only by the space available and 

the number of web conference lines 

available. Time will be available for 

public comment. 

DATES: The meeting will be held on 

April 17, 2024, from 8:30 a.m. to 4:10 

p.m., EDT. 

ADDRESSES: Mine Safety and Heath 

Administration’s Approval and 

Certification Center, 765 Technology 

Drive, Triadelphia, West Virginia 26059. 

The conference room accommodates 

approximately 49 people. 

Please note that the meeting location 

is a Federal facility and in-person access 

is limited to U.S. citizens unless prior 

authorizations, taking up to 30 to 60 

days, have been made. 

If you wish to attend the meeting 

either in person or virtually, please 

contact Ms. Berni Metzger by email at 

Metzger@cdc.gov or by phone at (412) 

386–4541 at least 5 business days in 

advance of the meeting. If you are 

attending virtually, she will provide you 

with the Zoom web conference access 

information (500 web conference lines 

are available). 

FOR FURTHER INFORMATION CONTACT: 

Steven Mischler, Ph.D., Designated 

Federal Officer, Mine Safety and Health 


khammond on DSKJM1Z7X2PROD with NOTICES
15580 Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices 

Research Advisory Committee, National 

Institute for Occupational Safety and 

Health, Centers for Disease Control and 

Prevention, 626 Cochrans Mill Road, 

Pittsburgh, Pennsylvania 15236. 

Telephone: (412) 386–5688; Email: 

SMischler@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Mine Safety and Health 

Research Advisory Committee is 

charged with providing advice to the 

Secretary, Department of Health and 

Human Services; the Director, Centers 

for Disease Control and Prevention; and 

the Director, National Institute for 

Occupational Safety and Health 

(NIOSH), on priorities in mine safety 

and health research, including grants 

and contracts for such research, 30 

U.S.C. 812(b)(2), Section 102(b)(2). 

Matters To Be Considered: The agenda 

will include discussions on NIOSH 

mining safety and health research 

organizational structure, capabilities, 

projects, and outcomes, as well as a 

verbal report from the Mace 

Development Workgroup. The meeting 

will also include an update from the 

NIOSH Associate Deputy Director, Mine 

Safety and Research. Agenda items are 

subject to change as priorities dictate. 

Public Participation 

Written Public Comment: The public 

may submit written comments or 

questions in advance of the meeting, to 

the Designated Federal Officer (see FOR

FURTHER INFORMATION CONTACT above). 

Written comments received in advance 

of the meeting will be included in the 

official record of the meeting, and 

questions will be answered during the 

oral comment period open to public 

participation. 

Oral Public Comment: The meeting 

will include time for members of the 

public to make an oral comment. The 

public comment session will be held on 

April 17, 2024, at 3:30 p.m., EDT, or the 

conclusion of the planned 

presentations, whichever comes first. 

Members of the public will be allocated 

5 to 10 minutes each for presentations 

or comments, as a function of the 

number of commenters. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–04433 Filed 3–1–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Advisory Board on 

Radiation and Worker Health, National 

Institute for Occupational Safety and 

Health 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control (CDC) 

announces a meeting of the Advisory 

Board on Radiation and Worker Health 

(ABRWH or the Advisory Board). This 

meeting is open to the public, with a 

public comment period. The public is 

welcome to submit written comments in 

advance of the meeting, to the contact 

person below. Written comments 

received in advance of the meeting will 

be included in the official record of the 

meeting. The public is also welcomed to 

listen to the meeting by joining the 

teleconference (information below). The 

audio conference line has 150 ports for 

callers. 

DATES: The meeting will be held on 

April 17, 2024, from 9:15 a.m. to 6 p.m., 

EDT. A public comment session will be 

held at 5 p.m. and will conclude at 6 

p.m. or following the final call for 

public comment, whichever comes first. 

Written comments must be received 

on or before April 10, 2024. 

ADDRESSES: You may submit comments 

by mail to: Rashaun Roberts, National 

Institute for Occupational Safety and 

Health, 1090 Tusculum Avenue, MS C– 

24, Cincinnati, Ohio 45226. 

Meeting Information: The USA tollfree dial-in numbers are: +1 669 254 

5252 US (San Jose); +1 646 828 7666 US 

(New York). The Meeting ID is: 160 

6763 3819 and the Passcode is: 

98685439; Web conference by Zoom 

meeting connection: https://

cdc.zoomgov.com/j/16067633819?pwd=

RUdiYXlZZHFKanpJOHZrcG

JIbTlaZz09. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, National Institute for 

Occupational Safety and Health, Centers 

for Disease Control and Prevention, 

1090 Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone 

(513) 533–6800, Toll Free 1(800) 232– 

4636, Email: ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines 

which have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule, advice on 

methods of dose reconstruction which 

have also been promulgated by HHS as 

a final rule, advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). In 

December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to the Centers for Disease 

Control and Prevention (CDC). The 

National Institute for Occupational 

Safety and Health implements this 

responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

and rechartered under Executive Order 

14109 on March 22, 2022, and will 

terminate on March 22, 2024. 

Purpose: This Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary 

on whether there is a class of employees 

at any Department of Energy (DOE) 

facility who were exposed to radiation 

but for whom it is not feasible to 

estimate their radiation dose, and on 

whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of 

this class. 

Matters to be Considered: The agenda 

will include discussions on the 


khammond on DSKJM1Z7X2PROD with NOTICES